title: Dr. Lund and colleagues reply.
authors.affiliation: Brian.Lund@va.gov.
authors.forename: Brian C
authors.initials: BC
authors.lastname: Lund
authors.forename: Nancy C
authors.initials: NC
authors.lastname: Bernardy
authors.forename: Bruce
authors.initials: B
authors.lastname: Alexander
authors.forename: Matthew J
authors.initials: MJ
authors.lastname: Friedman
mesh_terms: D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000627:therapeutic use*; D004363:Drug Utilization / Q000639:trends*; D005260:Female; D006801:Humans; D008297:Male; D010890:Pirenzepine / Q000031:analogs & derivatives*; D012559:Schizophrenia / Q000188:drug therapy*; D013313:Stress Disorders, Post-Traumatic / Q000188:drug therapy*; D014728:Veterans / Q000523:psychology*
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D010890:Pirenzepine